COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 1543: Articles 15421-15430  | Next

The SARS-CoV2 pandemic explained via asymptomatic infection and susceptibility heterogeneity. Buenos Aires First Wave
Bullo, M., Poy Pineiro, S., Cosatto, P., Seoane, H., Picasso, E.
10.1101/2021.04.26.21255801 — Posted: 2021-04-27
COVID-19 vaccine acceptance in older Syrian refugees: preliminary findings from an ongoing study
El Salibi, N., Abdulrahim, S., El Haddad, M., Bassil, S., El Khoury, Z., Ghattas, H., McCall, S.
10.1101/2021.04.25.21256024 — Posted: 2021-04-27
Performance Decay of Molecular Assays Near the Limit of Detection: Probabilistic Modeling using Real-World COVID-19 Data
Durant, T. J., Koch, C. D., Kerantzas, C. A., Peaper, D. R.
10.1101/2021.04.26.21254638 — Posted: 2021-04-27
It's complicated: characterizing the time-varying relationship between cell phone mobility and COVID-19 spread in the US
Jewell, S., Futoma, J., Hannah, L., Miller, A., Foti, N., Fox, E.
10.1101/2021.04.24.21255827 — Posted: 2021-04-27
SARS-CoV-2 subgenomic RNA kinetics in longitudinal clinical samples
Verma, R., Kim, E., Martinez-Colon, G. J., Jagannathan, P., Rustagi, A., Parsonnet, J., Bonilla, H., Khosla, C., Holubar, M., Subramanian, A., Singh, U., Maldonado, Y., Blish, C. A., Andrews, J. R.
10.1101/2021.04.26.21256131 — Posted: 2021-04-27
High proportion of post-acute sequelae of SARS-CoV-2 infection in individuals 1-6 months after illness and association with disease severity in an outpatient telemedicine population
O'Keefe, J. B., Minton, H. C., Morrow, M., Johnson, C., Moore, M. A., O'Keefe, G. A. D., Benameur, K., Higdon, J., Fairley, J. K.
10.1101/2021.04.24.21256054 — Posted: 2021-04-27
Stimulation of vascular organoids with SARS-CoV-2 antigens increases endothelial permeability and regulates vasculopathy
Khan, A. O., Reyat, J. S., Bourne, J. H., Colicchia, M., Newby, M. L., Allen, J. D., Crispin, M., Youd, E., Murray, P. G., Taylor, G. S., Stamataki, Z., Richter, A. G., Cunningham, A. F., Pugh, M., Rayes, J.
10.1101/2021.04.25.21255890 — Posted: 2021-04-27
Implementation of Rapid and Frequent SARS-CoV2 Antigen Testing and Response in Congregate Homeless Shelters
Aranda-Diaz, A., Imbert, E., Strieff, S., Graham-Squire, D., Evans, J., Moore, J., McFarland, W., Fuchs, J., Handley, M., Kushel, M. B.
10.1101/2021.04.20.21255787 — Posted: 2021-04-27
Interleukin-6 receptor genetic variation and tocilizumab treatment response to COVID-19
Almarzooq, A. A.
10.1101/2021.04.24.21256047 — Posted: 2021-04-27
Curating and translating the evidence about SARS-CoV-2 and COVID-19 for frontline public health and clinical care: The Novel Coronavirus Research Compendium (NCRC)
Redd, A. D., Peetluk, L., Brooke, J., Hanrahan, C., Schwartz, S., Rao, A., Jaffe, A., Jones, C., Lutz, C., McKee, C., Patel, E., Rosen, G., Desany, H. G., McKay, H., Muschelli, J., Anderson, K., Link, M. A., Wada, N., Baral, P., Young, R., Boon, D., Grabowski, M. K., Gurley, E. S., Novel Coronavirus Research Compendium (NCRC)
10.1101/2021.04.26.21255437 — Posted: 2021-04-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).